skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes

Original Research

(4144) Views  (1115) Full article downloads

Authors: Bradley Curtis, Risa P Hayes, Sheri Fehnel, Laurie Zografos

Published Date October 2008 Volume 2008:1 Pages 13 - 23
DOI: http://dx.doi.org/10.2147/DMSO.S4237

Bradley Curtis1, Risa P Hayes1, Sheri Fehnel2, Laurie Zografos2

1Global Health Outcomes, Eli Lilly and Co, Indianapolis, IN, USA; 2RTI Health Solutions, Research Triangle Park, NC, USA

Abstract: The objective of this study was to assess specific areas of life in which obesity affects individuals with type 2 diabetes mellitus (T2DM), and changes that obese persons with T2DM experience with weight loss of varying degrees. Thirty in-depth interviews were conducted in persons identified as: age ≥40 years, diagnosed with T2DM for ≥2 years, on oral antihyperglycemic medications >3 months, BMI 30–35 kg/m2, having attempted to lose weight in the last 2 years. Participants (60% female, mean age 53 years, 53% Caucasian, mean BMI 32.2 kg/m2) agreed that 5% weight loss, while not reflective of an ultimate goal, would be meaningful and important; benefits were expected to accrue in physical functioning, self-confidence, blood glucose levels, and motivation to keep losing weight. Participants reported the greatest effect of weight loss on energy, physical activity, mobility, pain, and clothes/appearance. Participants reported weight affecting mood, with feelings of depression and frustration most commonly described. This research indicates that weight loss is likely to affect health-related quality of life in obese individuals with T2DM. Given the purported weight loss benefits of many emerging diabetic medications, it will be important to include measures of weight-related quality of life in future clinical trials of these agents.

Keywords: health-related quality of life, obesity, type 2 diabetes, weight loss, patient-reported outcomes








Readers of this article also read:

Potential renovascular hypertension, space missions, and the role of magnesium
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Obesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
The economic impact of obesity in the United States
Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participants
Management of diabetes across the course of disease: minimizing obesity-associated complications
Obesity: considerations about etiology, metabolism, and the use of experimental models
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio